World's Best Scientists 2026 revealed!
Daniel J. Sargent

Daniel J. Sargent

D-Index & Metrics

Medicine

D-Index
128
Citations
115476
World Ranking
2635
National Ranking
1476

Overview

Daniel J. Sargent was affiliated with the Mayo Clinic in the United States and was involved in medical research primarily within the field of Medicine. Their research concentrated largely on Oncology, with a specific emphasis on colorectal cancer treatments and studies. Over their career, they also contributed to related subfields such as Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Economics and Econometrics, and Surgery.

Their work frequently addressed topics including colorectal cancer treatments and studies, genetic factors in colorectal cancer, cancer treatment and pharmacology, gastric cancer management and outcomes, lung cancer treatments and mutations, colorectal cancer surgical treatments, and colorectal cancer screening and detection.

Key publications by Daniel J. Sargent included the following:

  • "A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer" (2023) published in Journal of Clinical Oncology
  • "High-Density Linkage Map Construction and QTL Identification in a Diploid Blueberry Mapping Population" (2021) published in Frontiers in Plant Science
  • "Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology" (2020) published by UNC Libraries
  • "Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials" (2020) published in JCO Precision Oncology
  • "Developmental processes in the Rosaceae through the lens of DNA and RNA methylation" (2025) published in Planta

The scientist frequently published in venues such as UNC Libraries, Journal of Clinical Oncology, Frontiers in Plant Science, JCO Precision Oncology, and Planta.

Throughout their career, Daniel J. Sargent collaborated with several researchers, notably Richard M. Goldberg, Henry C. Pitot, Axel Grothey, Charles S. Fuchs, and Steven R. Alberts. Richard M. Goldberg was the most frequent coauthor, appearing in numerous joint publications.

Best Publications

  • New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

    Elizabeth Eisenhauer;Patrick Therasse;Jan Bogaerts;L.H. Schwartz

  • A comparison of laparoscopically assisted and open colectomy for colon cancer.

    Heidi Nelson;Daniel J Sargent;H Sam Wieand

  • Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

    Axel Grothey;Eric Van Cutsem;Alberto Sobrero;Salvatore Siena

  • A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

    Richard M. Goldberg;Daniel J. Sargent;Roscoe F. Morton;Charles S. Fuchs

  • Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer

    Christine M. Ribic;Daniel J. Sargent;Malcolm J. Moore;Malcolm J. Moore;Stephen N. Thibodeau

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea

  • Guidelines 2000 for Colon and Rectal Cancer Surgery

    Heidi Nelson;Nicholas Petrelli;Arthur Carlin;Jean Couture

  • Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

    Daniel J. Sargent;Silvia Marsoni;Genevieve Monges;Stephen N. Thibodeau

  • Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

    Carolyn C. Compton;L. Peter Fielding;Lawrence J. Burgart;Barbara Conley

  • Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy

    Scott Kopetz;George J. Chang;Michael J. Overman;Cathy Eng

  • Prognostic Factors in Colorectal Cancer

    Carolyn C. Compton;Carolyn C. Compton;L. Peter Fielding;Lawrence J. Burgart;Barbara Conley

  • Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial.

    James Fleshman;Daniel J. Sargent;Erin Green;Mehran Anvari

  • The genome of woodland strawberry ( Fragaria vesca )

    Vladimir Shulaev;Daniel J. Sargent;Ross N. Crowhurst;Todd C. Mockler

  • Survival of Patients With Advanced Colorectal Cancer Improves With the Availability of Fluorouracil-Leucovorin, Irinotecan, and Oxaliplatin in the Course of Treatment

    Axel Grothey;Daniel Sargent;Richard M. Goldberg;Hans Joachim Schmoll

  • Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

    Sharlene Gill;Charles L. Loprinzi;Daniel J. Sargent;Stephan D. Thomé

  • Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial

    James Fleshman;Megan Branda;Daniel J. Sargent;Anne Marie Boller

  • A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.

    Daniel J. Sargent;Richard M. Goldberg;Stacy D. Jacobson;John S. Macdonald

  • Short-term Quality-of-Life Outcomes Following Laparoscopic-Assisted Colectomy vs Open Colectomy for Colon Cancer: A Randomized Trial

    Jane C. Weeks;Heidi Nelson;Shari Gelber;Daniel Sargent

  • Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis

    Gastric (Global Advanced);Xavier Paoletti;Koji Oba

  • Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors

    Noralane M. Lindor;Lawrence J. Burgart;Olga Leontovich;Richard M. Goldberg

Frequent Co-Authors

Richard M. Goldberg
Richard M. Goldberg West Virginia University
Axel Grothey
Axel Grothey University of Tennessee at Knoxville
Aimery de Gramont
Aimery de Gramont Grenoble Alpes University
Marc Buyse
Marc Buyse Hasselt University
Roberto Labianca
Roberto Labianca Mario Negri Institute for Pharmacological Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure if becoming a physician is your only option? There are many related online degrees and career pathways that can lead to rewarding roles in the medical field.

For those seeking in-demand administrative roles, consider a low cost medical coding and billing online program. These programs typically require less time and investment than full medical degrees, yet offer strong employment prospects.

If hands-on patient care interests you, becoming a nurse is a popular, flexible route. Explore how much does online nursing school cost to find programs that fit your budget, or look at the cheapest online np programs to advance your nursing credentials and increase your scope of practice.

For those aiming for leadership or research roles, a phd in nursing can help you reach academic, executive, or advanced clinical positions.

These online programs offer flexibility and often lower tuition costs, making healthcare careers more accessible than ever.

Best Scientists Citing Daniel J. Sargent

Recently Published Articles